Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost of exome sequencing in epileptic encephalopathy: is it 'worth it'?

Archives of disease in childhood - 1 Mar 2018

Forman Eva B, Gorman Kathleen M, Conroy Judith, Arthur Neil, Grant Ciara, Ennis Sean, Allen Nicholas M, Lynch Sally Ann, King Mary D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Child, Preschool
Share to Cost-Benefit Analysis
Share to Electroencephalography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epilepsy

Share to Exome Sequencing

Share to Genetic Testing

Share to Quality of Life

Source

Identifiers

PMID: 28939639
DOI: 10.1136/archdischild-2017-313240

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost of exome sequencing in epileptic encephalopathy: is it 'worth it'?PMID 28939639Read ↗

Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.Semantic proximity Read ↗

Exploring the genetic etiology of drug-resistant epilepsy: incorporation of exome sequencing into practiceSemantic proximity Read ↗

Diagnostic Yield and Treatment Impact of Targeted Exome Sequencing in Early-Onset EpilepsySemantic proximity Read ↗

Diagnostic Yield and Treatment Impact of Targeted Exome Sequencing in Early-onset EpilepsySemantic proximity Read ↗

Exome sequencing as first-tier genetic testing in infantile-onset pharmacoresistant epilepsy: diagnostic yield and treatment impactSemantic proximity Read ↗

Reducing the Cost of the Diagnostic Odyssey in Early Onset Epileptic Encephalopathies.Semantic proximity Read ↗

Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy.Semantic proximity Read ↗

Whole-genome analysis for effective clinical diagnosis and gene discovery in early infantile epileptic encephalopathySemantic proximity Read ↗

The sacred disease: the puzzling genetics of epileptic disorders.Semantic proximity Read ↗

Whole-exome sequencing in intellectual disability; cost before and after a diagnosisSemantic proximity Read ↗

Diagnostic Exome Sequencing: A New Paradigm in NeurologySemantic proximity Read ↗

Are whole Exome and whole Genome Sequencing Approaches Cost-Effective? A Systematic Review of the LiteratureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.